Cyclo Therapeutics Inc. (CYTH)
Market Open
26 Mar, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
0. 72
0
0%
$
23.59M Market Cap
- P/E Ratio
- Div Yield
186,806 Volume
0 Eps
$ 0.72
Previous Close Want to track CYTH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cyclo Therapeutics, Inc. (CYTH) Reports Q3 Loss, Lags Revenue Estimates
Cyclo Therapeutics, Inc. (CYTH) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to loss of $0.29 per share a year ago.
Zacks | 1 year ago
Cyclo Therapeutics, Inc. (CYTH) Reports Q2 Loss, Misses Revenue Estimates
Cyclo Therapeutics, Inc. (CYTH) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $0.33 per share a year ago.
Zacks | 1 year ago
